PNC Financial Services Group
PCVX icon

PNC Financial Services Group’s Vaxcyte PCVX Stock Holding History

PNC Financial Services Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Sell
11,800
-3,156
-21% -$171K ﹤0.01% 1590
2026
Q1 		$869K Buy
14,956
+39
+0.3% +$2.12K ﹤0.01% 1359
2025
Q4 		$688K Buy
14,917
+514
+4% +$23K ﹤0.01% 1453
2025
Q3 		$519K Buy
14,403
+3,184
+28% +$105K ﹤0.01% 1612
2025
Q2 		$365K Buy
11,219
+1,619
+17% +$53.1K ﹤0.01% 1782
2025
Q1 		$362K Buy
9,600
+524
+6% +$41.9K ﹤0.01% 1757
2024
Q4 		$743K Buy
9,076
+1,397
+18% +$139K ﹤0.01% 1300
2024
Q3 		$877K Sell
7,679
-765
-9% -$68.9K ﹤0.01% 1232
2024
Q2 		$638K Buy
8,444
+1,080
+15% +$73.5K ﹤0.01% 1362
2024
Q1 		$503K Buy
7,364
+378
+5% +$26.2K ﹤0.01% 1531
2023
Q4 		$439K Buy
6,986
+1,411
+25% +$73.3K ﹤0.01% 1605
2023
Q3 		$284K Buy
5,575
+5,119
+1,123% +$253K ﹤0.01% 1869
2023
Q2 		$22.8K Buy
456
+339
+290% +$16.1K ﹤0.01% 3493
2023
Q1 		$4.39K Sell
117
-6
-5% -$255 ﹤0.01% 4083
2022
Q4 		$5.9K Buy
123
+23
+23% +$903 ﹤0.01% 3941
2022
Q3 		$2K Sell
100
-6
-6% -$152 ﹤0.01% 4201
2022
Q2 		$2K Buy
+106
New +$2.45K ﹤0.01% 4230

Other funds holding PCVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PNC Financial Services Group's PCVX Position: Q2 2026 in Review

PNC Financial Services Group reduced its Vaxcyte (PCVX) stake by 21% in Q2 2026, selling an estimated $171K and leaving 11,800 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

PNC Financial Services Group first reported a position in PCVX in Q2 2022 and has held it in 17 quarters since. The position peaked at $877K in Q3 2024. 165 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • PNC Financial Services Group held 11,800 shares of Vaxcyte worth $686K as of Q2 2026.
  • PNC Financial Services Group sold 3,156 Vaxcyte shares in Q2 2026, an estimated $171K.
  • Vaxcyte made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1590 holding.
  • PNC Financial Services Group first reported a position in Vaxcyte in Q2 2022 and has held it in 17 quarters since.
  • PNC Financial Services Group's Vaxcyte position peaked at $877K in Q3 2024.
  • 165 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.